Terms: = Lung cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Staging
9 results:
1. RUNX1 promotes proliferation and migration in non-small cell lung cancer cell lines via the mtor pathway.
Ma H; Jiang S; Yuan Y; Li J; Li Y; Lv Y; Du T; Guan J; Jiang X; Tian L; Zheng Q; Yang L; Li Q
FASEB J; 2023 Nov; 37(11):e23195. PubMed ID: 37801076
[TBL] [Abstract] [Full Text] [Related]
2. circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression.
Jia C; Yao Z; Lin Z; Zhao L; Cai X; Chen S; Deng M; Zhang Q
J Cell Physiol; 2021 Feb; 236(2):1252-1269. PubMed ID: 32667692
[TBL] [Abstract] [Full Text] [Related]
3. Phosphoinositide specific phospholipase Cγ1 inhibition-driven autophagy caused cell death in human lung adenocarcinoma A549 cells
Lu X; Fu H; Chen R; Wang Y; Zhan Y; Song G; Hu T; Xia C; Tian X; Zhang B
Int J Biol Sci; 2020; 16(8):1427-1440. PubMed ID: 32210730
[TBL] [Abstract] [Full Text] [Related]
4. Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma.
Alexander HR; Li CY; Kennedy TJ
Ann Surg Oncol; 2018 Aug; 25(8):2159-2164. PubMed ID: 29423664
[TBL] [Abstract] [Full Text] [Related]
5. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract] [Full Text] [Related]
6. [Relationship between expression of mtor and prognosis of early stage non-small cell lung cancer].
Cai W; Shi Y; Zhao Q
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):120-2. PubMed ID: 24796460
[TBL] [Abstract] [Full Text] [Related]
7. Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus.
Ding J; Tang J; Chen X; Men HT; Luo WX; Du Y; Ge J; Li C; Chen Y; Cheng K; Qiu M; Liu JY
Asian Pac J Cancer Prev; 2013; 14(10):5675-80. PubMed ID: 24289561
[TBL] [Abstract] [Full Text] [Related]
8. Composite anatomical-clinical-molecular prognostic model in non-small cell lung cancer.
López-Encuentra A; López-Ríos F; Conde E; García-Luján R; Suárez-Gauthier A; Mañes N; Renedo G; Duque-Medina JL; García-Lagarto E; Rami-Porta R; González-Pont G; Astudillo-Pombo J; Maté-Sanz JL; Freixinet J; Romero-Saavedra T; Sánchez-Céspedes M; Gómez de la Camara A;
Eur Respir J; 2011 Jan; 37(1):136-42. PubMed ID: 20817702
[TBL] [Abstract] [Full Text] [Related]
9. mtor activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesis.
Yu J; Henske EP
Lymphat Res Biol; 2010 Mar; 8(1):43-9. PubMed ID: 20235886
[TBL] [Abstract] [Full Text] [Related]